KASSAB, A. S. M. A. A. E., E. M. Gedawy, M. I. A. Hamed, and A. S. D. & R. A. Hassan, "Design, synthesis, anticancer evaluation and molecular modeling studies of novel tolmetin derivatives as potential VEGFR-2 inhibitors and apoptosis inducers", Journal of Enzyme Inhibition and Medicinal Chemistry, vol. 36, issue 1, pp. 922-939, 2021.
KASSAB, A. S. M. A. A. E., Y. El‐Dash, and E. M. Gedawy, "Novel pyrazolopyrimidine urea derivatives: Synthesis, antiproliferative activity, VEGFR‐2 inhibition, and effects on the cell cycle profile", Arch der Pharmazie, vol. 353, issue 4, pp. 1900319, 2020.
Ahmed, E. M., M. S. A. Hassan, A. A. El-Malah, and A. S. M. A. A. E. KASSAB, "New pyridazine derivatives as selective COX-2 inhibitors and potential antiinflammatory agents; design, synthesis and biological evaluation", Bioorganic Chemistry, vol. 95, pp. 103497, 2020.
Gedawy, E. M., A. S. M. A. A. E. KASSAB, and A. E. M. Kerdawy, "Design, synthesis and biological evaluation of novel pyrazole sulfonamide derivatives as dual COX-2/5-LOX inhibitors", European Journal of Medicinal Chemistry, vol. 189, pp. 112066, 2020.
Inas G. Shahin, K. M. O., A. T. T. Nader S. Abutaleb, M. S. N. Marwa Alhashimi, and A. M. S. ASMAA E. KASSAB, "Evaluation of N-phenyl-2-aminothiazoles for treatment of multi-drug resistant and intracellular Staphylococcus aureus infections", European Journal of Medicinal Chemistry, vol. 202, pp. 112497, 2020.
Shahin, I. G., N. S. Abutaleb, M. Alhashimi, and A. S. M. A. A. E. KASSAB, "Evaluation of N-phenyl-2-aminothiazoles for treatment of multi-drug resistant and intracellular Staphylococcus aureus infections", European Journal of Medicinal Chemistry, vol. 202, pp. 112497, 2020.
Ahmed, E. M., A. S. M. A. A. E. KASSAB, A. A. El-Malah, and M. S. A. Hassan, "Synthesis and biological evaluation of pyridazinone derivatives as selective COX-2 inhibitors and potential anti-inflammatory agents", European Journal of Medicinal Chemistry, vol. 171, pp. 25-37, 2019.
Maher, M., A. Kassab, A. F. Zaher, and Z. Mahmoud, "Novel pyrazolo[3,4-d]pyrimidines as potential cytotoxic agents: Design, synthesis, molecular docking and CDK2 inhibition", Anti-Cancer Agents in Medicinal Chemistry, vol. 19, pp. 1368-1381, 2019.
Maher, M., A. S. M. A. A. E. KASSAB, A. S. H. R. A. F. F. ZAHER, and Z. Mahmoud, "Novel pyrazolo[3,4-d]pyrimidines: design, synthesis, anticancer activity, dual EGFR/ErbB2 receptor tyrosine kinases inhibitory activity, effects on cell cycle profile and caspase-3-mediated apoptosis", JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY, vol. 34, issue 1, pp. 532–546, 2019.
Tourism